Evolution of the Average Target: Genmab A/S

Evolution of the Target Price: Genmab A/S

Changes in Analyst Recommendations: Genmab A/S

7074b4ccd.yGgU0cGVpIu0ANg01miHl0u7MWM8j6ZNWuIaE9p6u1w.oVtMlIL0y8bDMaJAgBu--j34XhVM3uUEGb13fqNCzzf5O2Wn7NLX5u12uw~0411ad8569b3079f1866a90e7079b31c
Aug. 31 Deutsche Bank raises Genmab price target to 2,500 Danish kroner (2,250), reiterates buy FW
Aug. 20 Cancer vaccines finally garner the spotlight Alphavalue
Aug. 20 AlphaValue/Baader Europe Downgrades Genmab to Add, Trims PT MT
Aug. 12 BNP Paribas Initiates Genmab at Outperform, With $40 Price Target MT
Aug. 07 Genmab: Q2 beat reinforces the investment story; diversification efforts remain on course Alphavalue
Aug. 07 UBS raises Genmab price target to 2,700 Danish kroner (2,600), reiterates buy FW
Aug. 07 Analysts upbeat on Genmab after strong Q2 FW
Aug. 07 Goldman Sachs raises Genmab target price to 2,400 Danish kroner (2,350), reiterates buy - BN FW
Aug. 07 TD Cowen raises Genmab price target to 2,892 Danish kroner (2,851), reiterates buy FW
Aug. 07 Jyske Bank raises Genmab target price to 2 350 Danish kroner (2 300), reiterates buy - BN FW
Aug. 07 Nordea raises its target price for Genmab to 2,083 Danish kroner (2,015), reiterates buy FW
Jul. 22 TD Cowen Upgrades Genmab to Buy Rating, Boosts PT MT
Jul. 22 TD Cowen Upgrades Genmab to Buy From Hold, Raises Price Target to $43 From $32 MT
Jul. 22 TD Cowen upgrades Genmab to buy (hold) - BN FW
Jul. 21 Goldman Sachs raises Genmab price target to 2,350 Danish kroner (2,300), reiterates buy - BN FW
Jul. 14 Where would AI lead Pharma in the long run? Alphavalue
Jul. 07 Genmab rebounds on a European Commission decision Zonebourse
Jul. 06 BNP Paribas raises the target price for Genmab to 2,500 Danish kroner (2,400), reiterates outperform - BN FW
Jun. 24 AlphaValue/Baader Europe Reduces EPS Estimates for Genmab on Merger Financing Costs MT
Jun. 23 Genmab: Financing weighs now, pipeline pays later Alphavalue
May. 18 Genmab Maintained at Buy as BofA Notes Upcoming Key Catalysts MT
May. 12 Nordea resumes coverage of Genmab with Buy rating and DKK 2,015 price target FW
May. 11 Genmab Rebounds on UBS Support Zonebourse
May. 11 Deutsche Bank trims Genmab price target to DKK 2,250 (2,400), reiterates Buy FW
May. 09 Genmab: Market mispricing creates opportunity as good Q1 reinforces investment thesis Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.85%
+9.86%
+10.81%
+68.87%
+17.86%
-13.15%
+12.58%
+20.2%
-2.66%
Average +15.69%
Weighted average by Cap. +16.34%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2,122.00DKK
Average target price
2,427.12DKK
Spread / Average Target
+14.38%
High Price Target
2,930.00DKK
Spread / Highest target
+38.08%
Low Price Target
1,400.00DKK
Spread / Lowest Target
-34.02%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-